University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
Rev Soc Bras Med Trop. 2010 Mar-Apr;43(2):129-34. doi: 10.1590/s0037-86822010000200005.
Abdominal palpation and ultrasound findings among patients from an endemic area for schistosomiasis in Brazil who had been followed up for 27 years were compared.
In 2004, 411 patients from Brejo do Espírito Santo, in the State of Bahia, were selected for the present investigation after giving their written informed consent. Based on clinical data, they were divided into three groups: 41 patients with evidence of liver fibrosis in 2004 (Group 1); 102 patients with evidence of liver fibrosis in the past (1976-1989) but not in 2004 (Group 2); and 268 patients without evidence of liver fibrosis at any time during the 27-year follow-up (Group 3). All of the patients underwent abdominal ultrasound in which the examiner did not know the result from the clinical examination. The data were stored in a database.
The prevalence of periportal fibrosis on ultrasound was 82.9%, 56.9% and 13.4% in Groups 1, 2 and 3, respectively. In the presence of hard, nodular liver or prominent left lobe and a hard palpable spleen, ultrasound revealed periportal fibrosis in 70.9%. However, periportal fibrosis was diagnosed using ultrasound in 25.4% of the patients in the absence of clinical evidence of liver involvement. Thus, ultrasound diagnosed periportal fibrosis 3.1 times more frequently than clinical examination did.
Although clinical examination is important in evaluating morbidity due to Manson's schistosomiasis in endemic areas, ultrasound is more accurate in diagnosing liver involvement and periportal fibrosis.
本研究比较了巴西血吸虫病流行地区 27 年随访患者的腹部触诊和超声表现。
2004 年,在巴伊亚州的 Brejo do Espírito Santo 选择了 411 名患者参与本研究,这些患者均签署了知情同意书。根据临床数据,他们被分为三组:2004 年有肝纤维化证据的 41 名患者(第 1 组);过去(1976-1989 年)有肝纤维化证据但 2004 年无肝纤维化证据的 102 名患者(第 2 组);27 年随访期间任何时间均无肝纤维化证据的 268 名患者(第 3 组)。所有患者均接受了腹部超声检查,检查者不知道临床检查结果。数据存储在数据库中。
第 1、2 和 3 组患者门静脉周围纤维化的超声检出率分别为 82.9%、56.9%和 13.4%。在存在硬结节性肝脏或左叶突出和可触及的硬脾的情况下,超声显示门静脉周围纤维化的检出率为 70.9%。然而,在没有临床肝脏受累证据的情况下,有 25.4%的患者通过超声诊断为门静脉周围纤维化。因此,超声诊断门静脉周围纤维化的频率比临床检查高 3.1 倍。
尽管临床检查在评估曼森血吸虫病流行地区的发病率很重要,但超声在诊断肝脏受累和门静脉周围纤维化方面更准确。